| Literature DB >> 1490494 |
Abstract
We report our experience with lamotrigine add-on therapy in the treatment of 11 patients with Lennox-Gastaut syndrome. Lamotrigine is a novel antiepileptic drug, chemically unrelated to the major anticonvulsants in current use. Ten patients experienced a > 50% reduction in seizure frequency, 1 patient experienced no change in seizure frequency. All patients tolerated lamotrigine satisfactorily and no side-effects were reported.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1490494 DOI： 10.1159/000116849
Source DB: PubMed Journal: Eur Neurol ISSN： 0014-3022 Impact factor: 1.710